Delivery Order SPE2DP16D0008-0048
Award Date 9/8/17
Potential Completion Date 9/10/18
Potential Value $151K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $179,992.80 firm fixed-price delivery order to Genentech USA, Inc. to provide the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceutical products. This order supports maintaining military medical readiness and was placed against an existing indefinite delivery contract. The contract has a completion date of September 12, 2018 and was awarded on...
- The Defense Logistics Agency Troop Support Medical awarded a $228,798.54 firm-fixed-price delivery order contract to Genentech USA, Inc. for the procurement of the antiviral medication oseltamivir phosphate. As a prime contractor, Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals, will deliver the drug to support the agency's medical mission. The agency did not use a set-aside for this contract. Genentech has previously provided various biologic medicines, including...
- This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...
- The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...
- This federal contract award, SPE2DP16D0008|0021, was made by the Medical Supply Chain division of the Defense agency to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $101,188.26 firm-fixed-price delivery order is for the antiviral medication oseltamivir phosphate, with a performance period ending on September 22, 2017. The award is not associated with a set-aside program. Genentech USA, Inc. is a major supplier of pharmaceuticals and biologics to federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals based in South San Francisco, California. The contract is for the supply of oseltamivir phosphate, an antiviral medication, with a ceiling value of $87,034.98. The contract is a firm-fixed-price delivery order that was awarded on September 28, 2016, with a completion date of September 28, 2017. The contract was not set aside for any...
- This is a federal contract award to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the delivery of oseltamivir phosphate, an antiviral medication. The contract award (SPE2DP18D0011|SPE2DP18F6027) has a ceiling value of $95,976.93 and was issued on a firm fixed-price basis as a delivery order, with a final completion date of September 23, 2019. Genentech is an established federal contractor, holding several vehicles with...
- This is a delivery order awarded to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals, by the Defense Logistics Agency Troop Support Medical. The contract is for the antiviral medication oseltamivir phosphate, with a potential value of $468,558.18 and a firm fixed price pricing type. The place of performance is Genentech's facility in South San Francisco, California. The contract does not utilize any set-asides. Genentech has extensive experience...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $74.97 million delivery order to Genentech USA, Inc. for the procurement of Xofluza (baloxavir marboxil) in 40mg and 80mg tablet formulations. This delivery order, which is firm fixed price with an ultimate completion date of September 29, 2027, was issued under Genentech's existing Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) and was awarded...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...